Key Terms
Course
Public Health in Pharmacy Practice: A Casebook, 2nd Edition
Chapter
37 - Bridging the Gap Between Oncology and Primary Care: A Multidisciplinary Approach
Result
Non-cancer comorbidities receive suboptimal management.
Demographics
73-year-old woman | 61 inches | 77 kg
Problem
Isolation, transportation barriers, financial hardship, poor diet, no exercise. Pharmacist action: Provide referrals (di
Pharmacist action
Flag as urgent. Recommend GI evaluation.
Definition
A structured review of all of a patient's medications to identify and resolve drug therapy problems, adverse effects, an
Who performs it
Pharmacists (primary care setting or MTM program)
Oral Anticancer Agent (OAA)
Cancer treatment taken orally (rather than IV); allows outpatient management but requires adherence monitoring and incre
Tyrosine Kinase Inhibitor (TKI)
Class of targeted cancer therapy that blocks kinase enzymes involved in tumor growth; can aggravate chronic conditions.
Endocrine/Hormonal Therapy
Cancer treatment that blocks or alters hormone activity; used in hormone-sensitive cancers (breast, prostate); induces m
Anthracyclines
Class of chemotherapy drugs (e.g., doxorubicin); associated with cardiotoxicity and cardiac failure.
Comprehensive Medication Review (CMR)
Structured pharmacist-led review of all medications to identify and resolve drug therapy problems.
Comorbidity
A disease or condition existing alongside a primary condition (here, cancer); affects treatment decisions and outcomes.
SDOH / Social Determinants of Health
Non-clinical social and environmental factors (income, housing, transportation, social support) that affect health outco